Recombinant Bovine Transmembrane protein FAM155A, also known as FAM155A, is a protein that, in humans, is primarily expressed in the hypothalamus and pituitary gland, with lower expression levels in the colon and blood . FAM155A is encoded by the FAM155A gene, which spans 703 kb and contains only three exons .
The FAM155A gene is located on chromosome 13 and spans a significant genomic region . It is characterized by a relatively simple structure, comprising only three exons within a 703 kb region .
FAM155A exhibits a distinct expression pattern across various tissues . It is predominantly expressed in the hypothalamus and pituitary gland . Lower expression levels have been observed in the colon and blood .
Genetic variations in FAM155A have been linked to an increased susceptibility to diverticulitis . The FAM155A variant rs67153654-A shows a significant association with diverticulitis .
Table 1: Association of FAM155A Variants with Diverticulitis
| Variant | Adjusted OR (95% CI) | P value |
|---|---|---|
| FAM155A rs67153654:T (ta + aa vs tt) | 1.09 (0.84–1.00) | 0.53 |
| FAM155A rs67153654:AT (ta vs tt + aa) | 1.02 (0.78–1.30) | 0.89 |
| FAM155A rs67153654:TT (tt vs at + aa) | 1.19 (0.67–2.10) | 0.56 |
FAM155A functions as an auxiliary subunit of the human sodium leak channel NALCN . Structural analysis reveals that the C-lobe of FAM155A contains a fold similar to the frizzled-like cysteine-rich domain (CRD) of receptor tyrosine kinase MuSK . Three disulfide bonds are structurally conserved between FAM155A and the CRD domain of MuSK .
Somatic mutations in the FAM155A gene have been observed in various types of cancer .
FAM159B, a protein related to FAM155A, has been examined across human, rat, and mouse species, revealing differences in expression in pancreatic islets . These differences suggest that findings on FAM159B obtained in animal models may not always be directly transferable to humans .
The FAM155A variant rs67153654-A is associated with diverticulitis, particularly in individuals who have developed the condition . This variant is less frequent in diverticulitis cases compared to uncomplicated diverticular disease, suggesting a protective role against infection or inflammation rather than influencing the integrity of the colon wall .
FAM155A (Family with Sequence Similarity 155 Member A), also known as NLF-1 (NCA Localization Factor 1), is an endoplasmic reticulum (ER) resident protein that functions as an auxiliary subunit of the NALCN (Sodium Leak Channel, Non-selective) channelosome. The primary function of FAM155A is to interact with NALCN and promote its neuronal localization . This interaction is crucial for the proper functioning of the sodium leak conductance, which plays a universal role in regulating the resting membrane potential (RMP) of neurons . FAM155A contains approximately 438-468 amino acids (depending on the species) and features a cysteine-rich domain (CRD) involved in signal transduction .
Based on recent structural studies, FAM155A contains:
One transmembrane domain near its C-terminus
A cysteine-rich domain (CRD) involved in signal transduction
One confirmed glycosylation site (Asn217)
Six disulfide bonds in its extracellular loops
The structure has been determined via cryo-EM at a resolution of 3.1 Å when complexed with NALCN . Electrostatic surface analysis revealed complementary surfaces between NALCN and FAM155A that ensure favorable interaction stability .
| Structural Feature | Details | Reference |
|---|---|---|
| Glycosylation site | Asn217 | |
| Disulfide bonds | Six bonds in extracellular loops | |
| Transmembrane domain | Near C-terminus | |
| Cysteine-rich domain | Involved in signal transduction |
FAM155A forms a stable complex with NALCN through specific interaction surfaces. The interaction involves:
Complementary electrostatic surfaces between the two proteins
Key conserved residues that are specific to NALCN (not conserved in other Nav/Cav channels)
Interaction with the second transmembrane domain of NALCN
Cross-linking mass spectrometry analysis has confirmed this complex structure . The interaction is highly specific, as the key residues in NALCN that mediate binding to FAM155A are not conserved among other Nav/Cav channels . This explains the selective association of FAM155A with NALCN rather than with other ion channels.
When designing experiments to study recombinant FAM155A, researchers should consider multiple expression systems based on their specific research questions:
HEK293FT cells: Suitable for electrophysiological studies of the NALCN-FAM155A complex, as demonstrated in patch-clamp recordings .
Xenopus laevis oocytes: Effective for studying interactions between FAM155A and NALCN pore .
E. coli, Yeast, Baculovirus, or Mammalian cell systems: All viable for recombinant protein expression depending on experimental requirements .
For structural studies requiring high protein yield and purity, insect cell expression systems have proven successful in obtaining stable NALCN-FAM155A complexes suitable for cryo-EM analysis . When designing functional studies, co-expression with other components of the channelosome (UNC79, UNC80) should be considered for a complete understanding of physiological function .
A methodological approach to studying FAM155A-NALCN interactions should include:
Define your variables:
Form a testable hypothesis:
For example: "Substitution of conserved residues in FAM155A will alter NALCN current conductance"
Experimental design:
Control experiments:
Expression level verification via Western blot
Subcellular localization via immunocytochemistry
Protein-protein interaction verification via co-immunoprecipitation or FRET
This experimental design allows for systematic testing of the functional significance of specific residues in FAM155A for NALCN channel function .
Based on successful structural studies of the NALCN-FAM155A complex, the following purification protocol is recommended:
Expression system selection: Use HEK293 cells for mammalian expression or insect cells for higher yields
Purification strategy:
Quality control:
Verify protein purity (>90%) using SDS-PAGE
Confirm identity via mass spectrometry
Assess structural integrity through circular dichroism
For structural studies specifically, the protocol that yielded high-quality samples for cryo-EM involved gel filtration purification with careful selection of peak fractions, followed by concentration to approximately 8.5 mg/ml .
To accurately measure functional effects of FAM155A mutations:
Electrophysiological approaches:
Data analysis parameters to measure:
Current density (pA/pF)
Voltage dependence of activation/inactivation
Reversal potential
Current kinetics (activation and inactivation rates)
As demonstrated in studies of NALCN mutations, electrophysiological analysis can reveal complex effects beyond simple increases or decreases in current magnitude. For example, the R1181Q mutation in NALCN was found to cause "significantly increased inward currents with a right shift, and reduced voltage sensitivity" rather than simply increasing conductance .
Additional functional assays:
Membrane trafficking assays to distinguish between trafficking defects and functional changes
FRET-based interaction assays to measure changes in protein-protein interaction strength
Surface biotinylation to quantify membrane expression levels
FAM155A research has significant implications for understanding neurological disorders through its critical role in the NALCN channelosome:
Neurodevelopmental disorders:
Neurophysiological mechanisms:
Therapeutic potential:
FAM155A represents a potential therapeutic target for modulating neuronal excitability
Understanding the structural basis of FAM155A-NALCN interaction could facilitate drug design targeting this complex
Research focused on the role of FAM155A in the sodium leak channelosome contributes fundamentally to understanding how neurons maintain their resting potential and how disruption of this process leads to disease .
The evolutionary conservation of FAM155A has several important implications:
Functional conservation:
Structural conservation:
Paralog evolution:
This evolutionary conservation highlights the fundamental importance of the NALCN-FAM155A interaction in neuronal physiology across the animal kingdom and suggests that insights gained from model organisms are likely applicable to human physiology and disease.
Researchers frequently encounter several challenges when working with recombinant FAM155A:
Low expression levels:
Solution: Optimize codon usage for the expression system
Solution: Use stronger promoters or inducible expression systems
Solution: Consider fusion tags that enhance expression (e.g., SUMO tag)
Protein instability:
Poor solubility:
Ensuring proper folding:
Solution: Verify the formation of critical disulfide bonds
Solution: Confirm glycosylation at Asn217
Solution: Use CD spectroscopy to assess secondary structure
Based on successful structural studies, co-expression with NALCN appears to be particularly effective for obtaining stable, properly folded FAM155A protein suitable for biochemical and structural analyses .
When encountering inconsistent electrophysiological results:
Verify protein expression levels:
Perform Western blot analysis to confirm consistent expression of all components
Use fluorescently tagged constructs to visualize expression in individual cells
Check membrane localization:
Ensure complete complex formation:
Control for recording conditions:
Standardize pipette and bath solutions
Control temperature during recordings
Account for series resistance and cell capacitance
Use consistent voltage protocols
Consider cell health and viability:
NALCN leak currents may affect cell viability
Use inducible expression systems to limit exposure time
Remember that when reconstituted in exogenous host cells, mutations can exert complex effects beyond simple increases or decreases in conductance, as demonstrated with the R1181Q NALCN mutation .
Based on current knowledge gaps, several promising research directions emerge:
Structural studies of the complete channelosome:
Investigation of FAM155B function:
Regulatory mechanisms of the NALCN-FAM155A complex:
Development of specific pharmacological tools:
Design compounds that specifically target the NALCN-FAM155A interface
Create tools to selectively modulate the sodium leak current
Role in disease models:
Generate and characterize FAM155A knockout or mutant animal models
Investigate the role of FAM155A in neurodevelopmental disorders
Study potential connections to neurodegenerative diseases
Several emerging technologies hold promise for advancing FAM155A research:
Cryo-electron tomography:
Visualize the NALCN-FAM155A complex in its native cellular environment
Study structural changes associated with channel gating or modulation
Single-molecule FRET:
Monitor dynamic conformational changes during channel gating
Study the kinetics of complex assembly
Advanced electrophysiological approaches:
Automated patch-clamp for high-throughput screening of mutations or compounds
Combined voltage-clamp fluorometry to correlate structural changes with function
CRISPR-based approaches:
Generate precise knock-in models with patient-specific mutations
Create cell type-specific conditional knockouts to study tissue-specific functions
Computational approaches:
Molecular dynamics simulations to understand channel gating
Virtual screening for compounds targeting the FAM155A-NALCN interface
AI-driven prediction of mutation effects on complex formation and function
These advanced technologies will enable researchers to address fundamental questions about FAM155A function and potentially develop therapeutic approaches targeting the NALCN channelosome.